Gene · 22937
Papers1,943
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,943
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cleaved SREBP-2 C-terminal fragment noncanonically drives interleukin-1 receptor-associated kinase 1-dependent apoptosis. | Signal Transduct Target Ther | 2026 | 41851104 | PubTator, text mining | PubMed |
| Functional interrogation of candidate cis-regulatory elements at the LDLR locus. | PLoS Genet | 2026 | 41843552 | PubTator, text mining | PubMed |
| Exploring sex bias in cardiometabolic diseases. | Lipids Health Dis | 2026 | 41840637 | PubTator, text mining | PubMed |
| INSIG1/2 succination mediated by the moonlighting function of ADSL promotes lipogenesis and liver tumorigenesis. | Nat Commun | 2026 | 41833955 | PubTator, text mining | PubMed |
| Scap stabilizes PKM2 to promote glycolysis and enhance anti-fungal immunity in macrophages. | Cell Rep | 2026 | 41831231 | PubTator, text mining | PubMed |
| Vitamin D Receptor Signaling and Ligand Modulation: Molecular Mechanisms and Therapeutic Implications. | Int J Mol Sci | 2026 | 41828612 | PubTator, text mining | PubMed |
| Advances in Targeting the AGEs-RAGE Pathway for the Treatment of Diabetic Kidney Disease. | Drug Des Devel Ther | 2026 | 41810125 | PubTator, text mining | PubMed |
| The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. | MedComm (2020) | 2026 | 41799937 | PubTator, text mining | PubMed |
| The compound LY295427 antagonizes 25-hydroxycholesterol through binding to INSIG. | J Lipid Res | 2026 | 41796682 | PubTator, text mining | PubMed |
| FOXN3 integrates the KU70/KU80/SREBP-1 complex to regulate lipid metabolism in non-alcoholic fatty liver disease. | Nucleic Acids Res | 2026 | 41761910 | PubTator, text mining | PubMed |
| A Global Perspective on Metabolic Dysfunction-Associated Steatotic Liver Disease: From Molecular Mechanisms to Therapeutic Strategy Innovation. | Nutrients | 2026 | 41754196 | PubTator, text mining | PubMed |
| Pulp-Dentin Regeneration via Cell Homing: Current Evidence and Perspectives on Cell-Free Regenerative Endodontic Therapy. | Medicina (Kaunas) | 2026 | 41752774 | PubTator, text mining | PubMed |
| The Paradox of Senescence in Glioblastoma: SASP as an Emerging Cancer Hallmark. | Cancers (Basel) | 2026 | 41749804 | PubTator, text mining | PubMed |
| A new mechanism for ubiquitination in polystyrene nanoplastic-induced spatial cognitive dysfunction through microglial activation-induced apoptosis of neurons. | J Hazard Mater | 2026 | 41734560 | PubTator, text mining | PubMed |
| Efficacy of dental stem cell-derived exosomes for pulp regeneration: a systematic review of clinical, animal, and in vitro studies. | Mol Biol Rep | 2026 | 41733701 | PubTator, text mining | PubMed |
| STAT1 signaling controls cholesterol metabolism in epithelial cells and RSV-induced syncytia formation. | Npj Viruses | 2026 | 41699197 | PubTator, text mining | PubMed |
| SREBP-1 increases glucose uptake to promote tumor resistance to lysosome inhibition. | Sci Transl Med | 2026 | 41604461 | PubTator, text mining | PubMed |
| Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment. | Exp Hematol Oncol | 2026 | 41588554 | PubTator, text mining | PubMed |
| Proteolysis-targeting chimera (PROTAC): A promising senolytic strategy. | Ageing Res Rev | 2026 | 41558613 | PubTator, text mining | PubMed |
| Competition between a transmembrane helix on Scap and a membrane cholesterol regulates Scap-Insig interaction and SREBP activation. | Proc Natl Acad Sci U S A | 2026 | 41474747 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22937/papers?page=2